Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- drugs and therapies 51 Treffer
- clinical research 49 Treffer
- cancer 39 Treffer
- oncology 39 Treffer
- pharmaceuticals 29 Treffer
-
45 weitere Werte:
- fda actions 22 Treffer
- government agencies offices and entities 22 Treffer
- biotechnology 20 Treffer
- fda 20 Treffer
- u.s. food and drug administration 20 Treffer
- risk and prevention 18 Treffer
- united states. food & drug administration 16 Treffer
- diagnostics and screening 14 Treffer
- gastroenterology 12 Treffer
- post-trial research 12 Treffer
- immunology 10 Treffer
- mortality 10 Treffer
- women's health 10 Treffer
- lung diseases and conditions 9 Treffer
- therapy 9 Treffer
- antineoplastics 8 Treffer
- biomarkers 8 Treffer
- epidemiology 8 Treffer
- viral 8 Treffer
- virology 8 Treffer
- asia 6 Treffer
- breast cancer 6 Treffer
- clinical medicine 6 Treffer
- digestive system diseases and conditions 6 Treffer
- enzymes and coenzymes 6 Treffer
- gene therapy 6 Treffer
- hospitals 6 Treffer
- liver diseases and conditions 6 Treffer
- nutritional and metabolic diseases and conditions 6 Treffer
- pre-trial research 6 Treffer
- prostate cancer 6 Treffer
- prostatic neoplasms 6 Treffer
- proteins 6 Treffer
- rna viruses 6 Treffer
- surgery 6 Treffer
- virus 6 Treffer
- bladder cancer 5 Treffer
- kinase inhibitors 5 Treffer
- lung cancer 5 Treffer
- lung neoplasms 5 Treffer
- protein kinase inhibitors 5 Treffer
- regulatory agencies 5 Treffer
- therapeutics 5 Treffer
- adverse drug reactions 4 Treffer
- androgens 4 Treffer
Sprache
Geographischer Bezug
Inhaltsanbieter
61 Treffer
-
In: Medical Letter on the CDC & FDA, 2023-11-03, S. 876-876serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-10-13, S. 17-17serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-07-14, S. 935-935serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-06-25, S. 1011-1011serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-01-30, S. 1671-1671serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-01-19, S. 529-529serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2023-09-22, S. 778-778serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-06-25, S. 1372-1372serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-06-18, S. 1205-1205serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-06-03, S. 738-738serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-06-03, S. 1691-1691serialPeriodicalZugriff:
-
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy.In: Medical Letter on the CDC & FDA, 2024-06-03, S. 34-34serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-05-20, S. 752-752serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-05-10, S. 26-26serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-04-19, S. 836-836serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-04-02, S. 249-249serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-03-25, S. 1539-1539serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-03-15, S. 335-335serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-03-01, S. 2375-2375serialPeriodicalZugriff:
-
In: Medical Letter on the CDC & FDA, 2024-01-30, S. 661-661serialPeriodicalZugriff: